Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

Cancer Issues Author: NYU School of Medicine Last Updated: Jun 30, 2010 - 6:09:13 PM



UVA Radiation Damages DNA in Human Melanocyte Skin Cells, Causing Mutations that Can Lead to Melanoma

By NYU School of Medicine
Jun 30, 2010 - 6:06:32 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page
(HealthNewsDigest.com) - New York, NY – A new study by researchers at NYU School of Medicine found that UVA radiation damages the DNA in human melanocyte cells, causing mutations that can lead to melanoma. Melanocytes, which contain a substance called melanin that darkens the skin to protect it from the ultraviolet rays of the sun, are more vulnerable to UVA radiation than normal skin cells because they are unable to repair themselves as efficiently.

“For the first time, UVA rays have been shown to cause significant damage to the DNA of human melanocyte skin cells,” says Moon-shong Tang, PhD, professor of environmental medicine, pathology and medicine at NYU School of Medicine. “And because melanocytes have a reduced capacity to repair DNA damage from UVA radiation, they mutate more frequently, potentially leading to the development of melanoma.”

In this study, researchers exposed lightly and darkly pigmented human melanocytes to UVA radiation and assessed DNA damage and the capacity of these cells to repair damaged DNA. DNA damage was detected in all melanocyte cells and these cells were unable to repair the damage. Normal skin cells were also exposed to UVA light but no damage to their DNA was observed.

“Identifying the underlying causes of melanoma allows researchers to develop new ways to assess a person’s risk of melanoma, prevent the disease and aid in the design of more effective treatments,” said Dr. Tang, who is also a member of the NYU Cancer Institute.

Sunlight in the form of UVA radiation causes oxygen in melanocytes to damage DNA. Thus, oxidative DNA damage adversely affects transcription and DNA replication in melanocytes. The authors concluded that UVA-induced oxidative DNA damage in melanocytes and the inherently reduced repair capacity in these cells are the two key factors that contribute to melanoma on the skin.

The authors also discovered the underlying mechanism to explain why melanoma can also develop in areas never exposed to sunlight: Because melanocytes generally have a limited capacity to repair any DNA damage, they have a higher mutation frequency rate and are more susceptible to the development of melanoma—even without the effects of the sun.

“Melanoma, the deadliest form of skin cancer, continues to increase at a rate of 3 percent a year,” says Dr. Tang. “This research highlights the necessity of limiting UVA radiation by avoiding excessive sunlight, tanning and sunbeds.”

The study received funding from the National Institutes of Health in Bethesda, Maryland. It was published early online and will be appear in the print edition of the Proceedings of the National Academy of Sciences on July 6, 2010.

Subscribe to our FREE Ezine and receive current Health News, be eligible for discounted products/services and coupons related to your Health. We publish 24/7.
HealthNewsDigest.com

For advertising or promotion, email: tvmike13@healthnewsdigest.com

Top of Page

HealthNewsDigest.com

Cancer Issues
Latest Headlines


+ How Early Breast Tumors Become Deadly
+ Targeting Tumors May Help Stop Spread of Breast, Other Cancers
+ Drug Extends Survival in Patients with Drug-Resistant Prostate Cancer
+ Gaining on Prostate Cancer
+ Breast Cancer Survivors Use At-Home Method to Prep Their Breasts for Reconstruction
+ Dopamine Doubles Medicine Levels In Tumors
+ Cell Permeable Peptide Identified that Inhibits Hepititis C Replication
+ Cancer Sequencing Initiative Discovers Mutations Tied to Aggressive Childhood Brain Tumors
+ Head & Neck Cancer in Transplant Patients: For Better or Worse?
+ Pinpoint Genomics Announces Publication of Clinical Study Results using its Pinpoint Dx Lung(TM) Assay in Lung Cancer



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions